ATLASPacific Biosciences of California (PACB) earnings date: Nov 4, 2026
Pacific Biosciences of California (PACB) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, after the close. Analysts expect EPS of -$0.13.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PACB
| Last price | $2.38 (-8.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±7.1% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 3 reports |
These figures come from the same calibrated model and valuation as the Pacific Biosciences of California stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Pacific Biosciences of California reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Pacific Biosciences of California. You can switch it off at any time.
Alert me before PACB reportsFree to start. Creating an account takes under a minute.
Notify me when Pacific Biosciences of California reports
Track PACB free Add Pacific Biosciences of California to a free ATLAS watchlist and see its next report date in one place.
PACB earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.13 |
| Last report | Aug 5, 2026 · Miss |
| Beat rate (last 3 reports) | 2 of 3 (67%) |
| Average EPS surprise | +2.6% |
| Average move around a report | ±14.5% (last 3) |
| Sector | Healthcare · Medical Devices |
Pacific Biosciences of California earnings history: last 3 reports
Pacific Biosciences of California last reported on Aug 5, 2026: EPS of -$0.14 against an estimate of -$0.13 (-7.7% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | -$0.13 | -$0.14 | -7.7% | Miss | -18.8% |
| May 7, 2026 | -$0.13 | -$0.12 | +7.7% | Beat | -17.5% |
| Feb 12, 2026 | -$0.13 | -$0.12 | +7.7% | Beat | -7.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PACB
See the fair value, the probability range and the earnings history of Pacific Biosciences of California on its ATLAS page.
Pacific Biosciences of California (PACB) stock analysisPlans from €3.99 a month.
Pacific Biosciences of California earnings: frequently asked questions
When does Pacific Biosciences of California (PACB) report earnings?
Pacific Biosciences of California is scheduled to report on Wednesday, November 4, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PACB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.13 per share (USD). Estimates can change before the report.
How often does PACB beat earnings estimates?
Of its last 3 reports with a recorded result, Pacific Biosciences of California beat the EPS estimate 2 times; the average surprise was +2.6%. Past results do not predict the next one.
How much does PACB move around earnings?
Over its last 3 reports the stock moved an average of 14.5% (absolute, from the close before the report day to the close after it), and finished higher 0 of 3 times.
Did Pacific Biosciences of California beat earnings estimates last quarter?
Pacific Biosciences of California last reported on Aug 5, 2026: EPS of -$0.14 against an estimate of -$0.13 (-7.7% surprise), a miss.
How much does PACB usually move in a day?
On a normal trading day the ATLAS model puts PACB’s one-day range at about ±7.1%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer